These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21620937)

  • 1. Post-exposure therapy with recombinant human BuChE following percutaneous VX challenge in guinea-pigs.
    Mumford H; Troyer JK
    Toxicol Lett; 2011 Sep; 206(1):29-34. PubMed ID: 21620937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-exposure therapy with human butyrylcholinesterase following percutaneous VX challenge in guinea pigs.
    Mumford H; E Price M; Lenz DE; Cerasoli DM
    Clin Toxicol (Phila); 2011 Apr; 49(4):287-97. PubMed ID: 21563904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human plasma-derived BuChE as a stoichiometric bioscavenger for treatment of nerve agent poisoning.
    Mumford H; Docx CJ; Price ME; Green AC; Tattersall JE; Armstrong SJ
    Chem Biol Interact; 2013 Mar; 203(1):160-6. PubMed ID: 22981459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and physiological effects of human butyrylcholinesterase as a post-exposure therapy against percutaneous poisoning by VX in the guinea-pig.
    Mumford H; Price ME; Cerasoli DM; Teschner W; Ehrlich H; Schwarz HP; Lenz DE
    Chem Biol Interact; 2010 Sep; 187(1-3):304-8. PubMed ID: 20176007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the guinea-pig.
    Mann TM; Price ME; Whitmore CL; Perrott RL; Laws TR; McColm RR; Emery ER; Tattersall JEH; Green AC; Rice H
    Toxicol Lett; 2018 Sep; 293():198-206. PubMed ID: 29183815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butyrylcholinesterase as a therapeutic drug for protection against percutaneous VX.
    Lenz DE; Clarkson ED; Schulz SM; Cerasoli DM
    Chem Biol Interact; 2010 Sep; 187(1-3):249-52. PubMed ID: 20513442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel approach to assessing percutaneous VX poisoning in the conscious guinea-pig.
    Mumford H; Price ME; Wetherell JR
    J Appl Toxicol; 2008 Jul; 28(5):694-702. PubMed ID: 18059069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of skin decontamination on the time window for effective treatment of percutaneous VX exposure.
    Joosen MJ; van den Berg RM; de Jong AL; van der Schans MJ; Noort D; Langenberg JP
    Chem Biol Interact; 2017 Apr; 267():48-56. PubMed ID: 26855350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-exposure treatment of VX poisoned guinea pigs with the engineered phosphotriesterase mutant C23: a proof-of-concept study.
    Worek F; Seeger T; Reiter G; Goldsmith M; Ashani Y; Leader H; Sussman JL; Aggarwal N; Thiermann H; Tawfik DS
    Toxicol Lett; 2014 Nov; 231(1):45-54. PubMed ID: 25195526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.
    Lenz DE; Yeung D; Smith JR; Sweeney RE; Lumley LA; Cerasoli DM
    Toxicology; 2007 Apr; 233(1-3):31-9. PubMed ID: 17188793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of bioscavenger in the medical management of nerve-agent poisoned casualties.
    Rice H; Mann TM; Armstrong SJ; Price ME; Green AC; Tattersall JEH
    Chem Biol Interact; 2016 Nov; 259(Pt B):175-181. PubMed ID: 27144491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of HI-6 DMS in a sustained infusion against percutaneous VX poisoning in the guinea-pig.
    Whitmore C; Cook AR; Mann T; Price ME; Emery E; Roughley N; Flint D; Stubbs S; Armstrong SJ; Rice H; Tattersall JEH
    Toxicol Lett; 2018 Sep; 293():207-215. PubMed ID: 29129798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo characterization of recombinant human butyrylcholinesterase (Protexia) as a potential nerve agent bioscavenger.
    Cerasoli DM; Griffiths EM; Doctor BP; Saxena A; Fedorko JM; Greig NH; Yu QS; Huang Y; Wilgus H; Karatzas CN; Koplovitz I; Lenz DE
    Chem Biol Interact; 2005 Dec; 157-158():363-5. PubMed ID: 16429486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and efficacy of atropine sulfate/obidoxime chloride co-formulation against VX in a guinea pig model.
    Kentrop J; Savransky V; Klaassen SD; van Groningen T; Bohnert S; Cornelissen AS; Cochrane L; Barry J; Joosen MJA
    Regul Toxicol Pharmacol; 2021 Feb; 119():104823. PubMed ID: 33212192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy studies of Reactive Skin Decontamination Lotion, M291 Skin Decontamination Kit, 0.5% bleach, 1% soapy water, and Skin Exposure Reduction Paste Against Chemical Warfare Agents, part 1: guinea pigs challenged with VX.
    Braue EH; Smith KH; Doxzon BF; Lumpkin HL; Clarkson ED
    Cutan Ocul Toxicol; 2011 Mar; 30(1):15-28. PubMed ID: 20942572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The percutaneous toxicokinetics of VX in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant.
    Lydon H; Hall C; Matar H; Dalton C; Chipman JK; Graham JS; Chilcott RP
    J Appl Toxicol; 2018 Mar; 38(3):318-328. PubMed ID: 29023806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 4-pyridine aldoxime on nerve agent-inhibited acetylcholinesterase activity in guinea pigs.
    Shih TM; Skovira JW; McDonough JH
    Arch Toxicol; 2009 Dec; 83(12):1083-9. PubMed ID: 19763542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of brain acetylcholinesterase by monoisonitrosoacetone increases the therapeutic efficacy against nerve agents in guinea pigs.
    Skovira JW; O'Donnell JC; Koplovitz I; Kan RK; McDonough JH; Shih TM
    Chem Biol Interact; 2010 Sep; 187(1-3):318-24. PubMed ID: 20230808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Butyrylcholinesterase in guinea pig lung lavage: a novel biomarker to assess lung injury following inhalation exposure to nerve agent VX.
    Graham JR; Wright BS; Rezk PE; Gordon RK; Sciuto AM; Nambiar MP
    Inhal Toxicol; 2006 Jun; 18(7):493-500. PubMed ID: 16603480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review.
    Joosen MJ; van der Schans MJ; Kuijpers WC; van Helden HP; Noort D
    Chem Biol Interact; 2013 Mar; 203(1):149-53. PubMed ID: 23085122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.